OTC:PTPI | Income Statement | Petros Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$988,501.00$988,501.00-$988,501.00-$955,625.00-$955,625.00-$0.30-$0.3047,391,73347,391,733
2026-03-31$1.03M$1.03M-$1.03M-$987,036.00-$987,036.00-$0.03-$0.0346,222,50246,222,502
2025-12-31$391,486.00$391,486.00-$391,486.00-$336,506.00-$336,506.00$0.39$0.394,791,7984,791,798
2025-09-30$990,737.00$990,737.00-$990,737.00-$922,723.00-$922,723.00-$0.03-$0.0342,284,50242,284,502
2025-06-30$1.8M$1.8M-$1.8M-$2.04M$5.43M-$1.20-$1.2025,922,50325,922,503
2025-03-31$1.46M$1.46M-$1.46M-$1.2M-$2.26M-$9.37-$9.371,161,7911,161,791
2024-12-31$725,403.00$264,754.00$460,649.00$101,945.00$577,554.00$577,554.00-$577,554.00-$552,813.00-$9.27M-$12.20-$12.2027,76127,761
2024-09-30$1.58M$287,005.00$1.29M$588,355.00$1.2M$1.2M-$1.2M-$919,541.00-$2.22M-$16.65-$16.65393,192393,192
2024-06-30$1.42M$329,110.00$1.09M$368,798.00$1.35M$1.35M-$1.35M$384,288.00-$662,026.00-$9.25-$9.25295,524295,524
2024-03-31$1.39M$331,831.00$1.06M$1.56M$1.5M$1.5M-$1.5M$382,893.00-$2.16M-$42.19-$42.19190,278190,278
2023-12-31-$364,250.00$158,147.00-$522,397.00$834,334.00$2.88M$4.52M-$5.04M$318,150.00$318,150.00-$1.62-$1.6267,27067,270
2023-09-30$1.67M$408,475.00$1.27M$389,093.00$2M$6.07M-$4.81M-$4.55M-$4.55M-$2.85-$2.852,119,6202,119,620
2023-06-30$1.99M$513,857.00$1.48M$866,575.00$2.25M$3.94M-$2.46M-$2.55M-$2.55M-$1.20-$1.202,117,5812,117,581
2023-03-31$2.52M$550,742.00$1.97M$319,093.00$2.13M$3.28M-$1.31M-$1.39M-$1.39M-$0.66-$0.662,088,6982,088,698
2022-12-31$798,101.00$881,332.00-$83,231.00$177,762.00$2.92M$4.02M-$4.1M-$4.23M-$4.22M-$2.03-$2.031,7381,738
2022-09-30$286,525.00-$1.74M$735,916.00$2.17M$11.93M-$13.67M-$13.82M$10,501.00-$13.83M-$6.69-$6.692,068,4722,068,472
2022-06-30$4.19M$649,220.00$3.54M$421,242.00$3.22M$5.2M-$1.66M-$1.81M-$1.81M-$0.88-$0.882,068,4722,068,472
2022-03-31$2.47M$472,340.00$1.99M$405,360.00$3.9M$2.47M-$481,198.00-$174,224.00-$0.08-$0.082,068,4722,068,472
2021-12-31-$867,160.00$243,728.00-$1.11M$988,688.00$4.18M$6.86M-$7.97M-$8.19M-$9,045.00-$8.19M-$8.17-$8.17-8,705,290-8,705,290
2021-09-30$2.15M$319,158.00$1.83M$280,576.00$3.41M$5.42M-$3.6M-$1.69M$2,345.00-$1.7M-$0.17-$0.179,826,5999,826,599
2021-06-30$2.46M$393,294.00$2.06M$500,046.00$4.12M$6.35M-$4.28M-$2.11M$6,700.00-$2.11M-$0.22-$0.229,802,3099,802,309
2021-03-31$4.08M$643,386.00$3.43M$19,181.00$3.88M$5.63M-$2.2M$3.01M$3.01M$0.31$0.319,753,0869,754,686
2020-12-31$2.93M$1.74M$1.19M$151,840.00$3.68M$5.51M-$4.32M-$6.82M-$1.38M-$5.44M$0.56$0.561,906,1311,906,131
2020-09-30$3.46M$981,903.00$2.48M$36,828.00$3.12M$4.82M-$2.34M-$3.31M-$6,143.00-$3.3M-$0.96-$0.963,434,5513,434,551
2020-06-30$1.37M$539,231.00$834,333.00$131,583.00$4.06M$5.85M-$5.02M-$5.78M-$13,781.00-$5.76M3,434,5513,434,551
2020-03-31$1.79M$784,035.00$1.01M$139,385.00$4.82M$6.62M-$5.61M-$6.11M-$29,971.00-$6.08M4,949,6104,949,610

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$4.64M$4.64M-$4.64M-$4.5M$0.00$1.91M-$1.56-$1.5628,065,36228,065,362
2024-12-31$5.11M$1.21M$3.9M$2.62M$4.63M$4.63M-$4.63M-$705,174.00$0.00-$14.32M-$83.47-$83.47321,042321,042
2023-12-31$5.82M$1.63M$4.19M$2.41M$9.26M$17.81M-$13.62M-$8.16M$0.00-$8.16M-$6.35-$6.352,176,0172,176,017
2022-12-31$5.99M$2.29M$3.7M$1.74M$12.21M$23.62M-$19.92M-$20.04M-$20.04M-$9.68-$9.682,070,2102,070,210
2021-12-31$7.81M$1.6M$6.21M$1.79M$15.59M$24.26M-$18.05M-$8.99M$0.00-$8.99M-$8.25-$8.251,088,9771,088,977
2020-12-31$9.56M$4.05M$5.51M$459,636.00$15.67M$22.8M-$17.28M-$22.01M-$1.43M-$20.59M-$3.85-$3.855,340,6825,340,682